Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C13H17N5O8S2 |
Molecular Weight | 435.433 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 1 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
C[C@H]1[C@H](NC(=O)C(=N/OC(C)(C)C(O)=O)\C2=CSC(N)=N2)C(=O)N1S(O)(=O)=O
InChI
InChIKey=WZPBZJONDBGPKJ-VEHQQRBSSA-N
InChI=1S/C13H17N5O8S2/c1-5-7(10(20)18(5)28(23,24)25)16-9(19)8(6-4-27-12(14)15-6)17-26-13(2,3)11(21)22/h4-5,7H,1-3H3,(H2,14,15)(H,16,19)(H,21,22)(H,23,24,25)/b17-8-/t5-,7-/m0/s1
Molecular Formula | C13H17N5O8S2 |
Molecular Weight | 435.433 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 1 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:46:15 UTC 2023
by
admin
on
Fri Dec 15 15:46:15 UTC 2023
|
Record UNII |
G2B4VE5GH8
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NDF-RT |
N0000011311
Created by
admin on Fri Dec 15 15:46:15 UTC 2023 , Edited by admin on Fri Dec 15 15:46:15 UTC 2023
|
||
|
NDF-RT |
N0000011311
Created by
admin on Fri Dec 15 15:46:15 UTC 2023 , Edited by admin on Fri Dec 15 15:46:15 UTC 2023
|
||
|
LIVERTOX |
NBK548462
Created by
admin on Fri Dec 15 15:46:15 UTC 2023 , Edited by admin on Fri Dec 15 15:46:15 UTC 2023
|
||
|
FDA ORPHAN DRUG |
155002
Created by
admin on Fri Dec 15 15:46:15 UTC 2023 , Edited by admin on Fri Dec 15 15:46:15 UTC 2023
|
||
|
NDF-RT |
N0000011311
Created by
admin on Fri Dec 15 15:46:15 UTC 2023 , Edited by admin on Fri Dec 15 15:46:15 UTC 2023
|
||
|
NDF-RT |
N0000011311
Created by
admin on Fri Dec 15 15:46:15 UTC 2023 , Edited by admin on Fri Dec 15 15:46:15 UTC 2023
|
||
|
NCI_THESAURUS |
C260
Created by
admin on Fri Dec 15 15:46:15 UTC 2023 , Edited by admin on Fri Dec 15 15:46:15 UTC 2023
|
||
|
WHO-VATC |
QJ01DF01
Created by
admin on Fri Dec 15 15:46:15 UTC 2023 , Edited by admin on Fri Dec 15 15:46:15 UTC 2023
|
||
|
NDF-RT |
N0000011311
Created by
admin on Fri Dec 15 15:46:15 UTC 2023 , Edited by admin on Fri Dec 15 15:46:15 UTC 2023
|
||
|
WHO-ATC |
J01DF01
Created by
admin on Fri Dec 15 15:46:15 UTC 2023 , Edited by admin on Fri Dec 15 15:46:15 UTC 2023
|
||
|
NDF-RT |
N0000011311
Created by
admin on Fri Dec 15 15:46:15 UTC 2023 , Edited by admin on Fri Dec 15 15:46:15 UTC 2023
|
||
|
NDF-RT |
N0000011311
Created by
admin on Fri Dec 15 15:46:15 UTC 2023 , Edited by admin on Fri Dec 15 15:46:15 UTC 2023
|
||
|
NDF-RT |
N0000011311
Created by
admin on Fri Dec 15 15:46:15 UTC 2023 , Edited by admin on Fri Dec 15 15:46:15 UTC 2023
|
||
|
FDA ORPHAN DRUG |
266208
Created by
admin on Fri Dec 15 15:46:15 UTC 2023 , Edited by admin on Fri Dec 15 15:46:15 UTC 2023
|
||
|
NDF-RT |
N0000175493
Created by
admin on Fri Dec 15 15:46:15 UTC 2023 , Edited by admin on Fri Dec 15 15:46:15 UTC 2023
|
||
|
NDF-RT |
N0000011311
Created by
admin on Fri Dec 15 15:46:15 UTC 2023 , Edited by admin on Fri Dec 15 15:46:15 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
278-839-9
Created by
admin on Fri Dec 15 15:46:15 UTC 2023 , Edited by admin on Fri Dec 15 15:46:15 UTC 2023
|
PRIMARY | |||
|
5742832
Created by
admin on Fri Dec 15 15:46:15 UTC 2023 , Edited by admin on Fri Dec 15 15:46:15 UTC 2023
|
PRIMARY | |||
|
m2188
Created by
admin on Fri Dec 15 15:46:15 UTC 2023 , Edited by admin on Fri Dec 15 15:46:15 UTC 2023
|
PRIMARY | Merck Index | ||
|
SUB05664MIG
Created by
admin on Fri Dec 15 15:46:15 UTC 2023 , Edited by admin on Fri Dec 15 15:46:15 UTC 2023
|
PRIMARY | |||
|
C28845
Created by
admin on Fri Dec 15 15:46:15 UTC 2023 , Edited by admin on Fri Dec 15 15:46:15 UTC 2023
|
PRIMARY | |||
|
161680
Created by
admin on Fri Dec 15 15:46:15 UTC 2023 , Edited by admin on Fri Dec 15 15:46:15 UTC 2023
|
PRIMARY | |||
|
CHEMBL3545256
Created by
admin on Fri Dec 15 15:46:15 UTC 2023 , Edited by admin on Fri Dec 15 15:46:15 UTC 2023
|
PRIMARY | |||
|
G2B4VE5GH8
Created by
admin on Fri Dec 15 15:46:15 UTC 2023 , Edited by admin on Fri Dec 15 15:46:15 UTC 2023
|
PRIMARY | |||
|
Aztreonam
Created by
admin on Fri Dec 15 15:46:15 UTC 2023 , Edited by admin on Fri Dec 15 15:46:15 UTC 2023
|
PRIMARY | |||
|
78110-38-0
Created by
admin on Fri Dec 15 15:46:15 UTC 2023 , Edited by admin on Fri Dec 15 15:46:15 UTC 2023
|
PRIMARY | |||
|
646279
Created by
admin on Fri Dec 15 15:46:15 UTC 2023 , Edited by admin on Fri Dec 15 15:46:15 UTC 2023
|
PRIMARY | |||
|
G2B4VE5GH8
Created by
admin on Fri Dec 15 15:46:15 UTC 2023 , Edited by admin on Fri Dec 15 15:46:15 UTC 2023
|
PRIMARY | |||
|
DTXSID0022640
Created by
admin on Fri Dec 15 15:46:15 UTC 2023 , Edited by admin on Fri Dec 15 15:46:15 UTC 2023
|
PRIMARY | |||
|
DB00355
Created by
admin on Fri Dec 15 15:46:15 UTC 2023 , Edited by admin on Fri Dec 15 15:46:15 UTC 2023
|
PRIMARY | |||
|
100000091595
Created by
admin on Fri Dec 15 15:46:15 UTC 2023 , Edited by admin on Fri Dec 15 15:46:15 UTC 2023
|
PRIMARY | |||
|
279
Created by
admin on Fri Dec 15 15:46:15 UTC 2023 , Edited by admin on Fri Dec 15 15:46:15 UTC 2023
|
PRIMARY | |||
|
D001398
Created by
admin on Fri Dec 15 15:46:15 UTC 2023 , Edited by admin on Fri Dec 15 15:46:15 UTC 2023
|
PRIMARY | |||
|
1272
Created by
admin on Fri Dec 15 15:46:15 UTC 2023 , Edited by admin on Fri Dec 15 15:46:15 UTC 2023
|
PRIMARY | RxNorm | ||
|
AZTREONAM
Created by
admin on Fri Dec 15 15:46:15 UTC 2023 , Edited by admin on Fri Dec 15 15:46:15 UTC 2023
|
PRIMARY | |||
|
5159
Created by
admin on Fri Dec 15 15:46:15 UTC 2023 , Edited by admin on Fri Dec 15 15:46:15 UTC 2023
|
PRIMARY | |||
|
758913
Created by
admin on Fri Dec 15 15:46:15 UTC 2023 , Edited by admin on Fri Dec 15 15:46:15 UTC 2023
|
PRIMARY | |||
|
1046205
Created by
admin on Fri Dec 15 15:46:15 UTC 2023 , Edited by admin on Fri Dec 15 15:46:15 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET ORGANISM->INHIBITOR |
Indicated for the suppressive therapy of chronic pulmonary infections due to Pseudomonas
aeruginosa in patients with cystic fibrosis (CF) aged 6 years and older.
|
||
|
BINDER->LIGAND |
BINDING
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
BASIS OF STRENGTH->SUBSTANCE |
ASSAY (HPLC)
USP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE INACTIVE -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
Open-ring aztreonam and open-ring desulfated aztreonam coelute. The limit is for the sum of these two impurities (1.0 WEUGHT PERCENT)
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
Open-ring aztreonam and open-ring desulfated aztreonam coelute. The limit is for the sum of these two impurities (1.0 WEIGHT PERCENT)
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Volume of Distribution | PHARMACOKINETIC |
|
|
|||
Cmax | PHARMACOKINETIC |
|
Amount Administered PHARMACOKINETIC PHARMACOKINETIC PHARMACOKINETIC PHARMACOKINETIC |
|
||
Biological Half-life | PHARMACOKINETIC |
|
|
|||